First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Stock Price Down 0.7% – Here’s Why

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBTGet Free Report) shares fell 0.7% on Thursday . The stock traded as low as GBX 1,583.30 ($20.44) and last traded at GBX 1,583.30 ($20.44). 1,365 shares were traded during trading, a decline of 91% from the average session volume of 15,968 shares. The stock had previously closed at GBX 1,594.60 ($20.59).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Up 0.6 %

The stock has a market cap of £655.07 million and a price-to-earnings ratio of -1,451.73. The firm’s 50-day moving average is GBX 1,708.72 and its two-hundred day moving average is GBX 1,648.91.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Read More

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.